|
Now in its third edition, Osteoporosis is the most comprehensive,
authoritative reference on this disease. Written by renowned experts
in the field, this two-volume reference is a must-have for academic
and medical libraries and physicians. Worldwide, 200 million women
between 60-80 years of age suffer from osteoporosis and have a
lifetime risk of fracture between 30 and 40 percent continuing
to make osteoporosis a hot topic in medicine. This newest edition
covers everything from basic anatomy and physiology to diagnosis,
management and treatment in a field where direct care costs for
osteoporitic fractures in the U.S. reach up to $18 billion each
year. Academic and medical libraries, as well as professionals
in bone biology, endocrinology, osteology, neuroendocrinology and
drug companies developing osteoporosis medications will find all
of their information needs met in this classic reference.
NEW TO
THIS EDITION:
- Offers critical reviews of reproductive and hormonal
risk factors, ethnicity, nutrition, therapeutics, management,
and economics comprising a tremendous wealth of knowledge in
a single source not found elsewhere
- Examines essential updates on estrogen prevention
and treatment and the recent results from the Women's Health
Initiative
- Recognizes
the critical importance of the Wnt signaling pathway for bone
health
- Incorporates new chapters on osteocytes, phosphatonins,
mouse genetics, and CNS and bone
- Discusses the controversial topics of
screening and clinical trial design for drug registration
- Includes essential updates on therapeutic
uses of calcium, vitamin D, SERMS, bisphosphonates, and parathyroid
hormone
September 2007, Hardback c. 1900 pp.
ISBN: 9780123705440
$320.00 / €270.00 / £185.00
List Print Price:
$400.00 / €335.00 / £230.00 / A$4,65.00 (GST included)
|
|
